ASCI Raises Concerns Over Nutraceutical Advertising in India
India’s nutraceutical and dietary supplement industry is attracting growing consumer interest, with products promising benefits ranging from weight management and improved skin health to enhanced immunity and respiratory wellness. However, how much scientific evidence supports these promises?
A report released by the Advertising Standards Council of India (ASCI) in October 2026 has raised important questions about the credibility of health and wellness claims in nutraceutical advertisements.
Titled A Pill for Thought: Review of Health and Wellness Claims in Nutraceutical Advertising, the report examined 61 advertisements published between July and September 2026. Of the 60 cases where the review process was completed, all 60 were found to violate the ASCI Code because advertisers failed to provide adequate substantiation for their claims. One additional case remained under review at the time of reporting.
The findings highlight a significant concern for consumers: advertisements may promise dramatic health improvements without sufficient evidence that the advertised product can actually deliver those results.
For consumers, healthcare professionals, supplement manufacturers and digital marketers, the report offers an important reminder that health-related advertising must be supported by credible scientific evidence.
What Is ASCI, and Why Does Its Report Matter?
The Advertising Standards Council of India (ASCI) is a self-regulatory organisation that works to promote responsible advertising and protect consumers against misleading advertisements.
Its advertising code emphasises that advertising claims should be truthful, should not mislead consumers and should be capable of being substantiated when challenged.
ASCI’s latest nutraceutical review is particularly significant because health-related purchasing decisions can have consequences beyond financial loss. Consumers may spend money on ineffective products or delay seeking appropriate medical advice because they believe an advertised supplement can address their health concerns.
The report also highlights the importance of distinguishing between products intended to supplement a person’s diet and treatments designed to manage specific medical conditions.
The central issue is not whether nutraceuticals can have legitimate nutritional or physiological benefits. It is whether the claims made in advertisements accurately reflect the available evidence for the particular product.
Key Findings of the ASCI Nutraceutical Advertising Report
The report identified recurring problems in how nutraceutical brands communicated product benefits.
1. All 60 Completed Advertisement Reviews Violated the ASCI Code
The most striking finding was the 100% violation rate among completed reviews.
ASCI examined 61 advertisements during its investigation. Of these:
- 60 advertisements: Review completed, with all 60 found to violate the ASCI Code.
- 29 advertisements: Advertisers did not contest the objections.
- 31 advertisements: Advertisers contested the objections but failed to provide adequate evidence supporting their claims.
- 1 advertisement: The case remained under process.
These findings indicate widespread problems with claim substantiation among the advertisements reviewed. However, they should not be interpreted as evidence that every nutraceutical product in India is ineffective or unsafe. The review concerned advertising claims, not a comprehensive scientific assessment of the entire nutraceutical market.
2. Weight Loss and Fat-Burning Promises Under Scrutiny
Weight management emerged as a prominent category in the investigation.
Some advertisements used specific timelines and dramatic promises to suggest that consumers could achieve substantial weight loss within a short period.
For example, the report highlighted claims such as losing six kilograms in 60 days.
Such promises can create unrealistic expectations, particularly when advertisements do not adequately explain the evidence supporting the stated outcome.
Weight changes depend on several factors, including diet, physical activity, individual health conditions and the overall energy balance. A supplement’s effectiveness cannot be established simply by presenting an attractive before-and-after image or a fixed weight-loss target.
What consumers should remember: Be cautious of supplements promising guaranteed fat loss, rapid weight reduction or targeted fat removal without credible evidence supporting the specific claim.
3. Anti-Ageing and Younger-Looking Skin Claims
The report also identified concerns involving advertisements that promoted anti-ageing benefits and dramatic improvements in skin appearance.
Some claims suggested that products could make consumers look several years younger or deliver substantial improvements within a defined period.
Although certain nutrients and ingredients may have recognised roles in normal skin function, this does not automatically establish that a finished supplement can reverse ageing or produce the advertised cosmetic outcome.
Consumers should distinguish between a product’s established nutritional role and a specific promise about visible changes in appearance.
Brands should be particularly careful when using age-reversal claims, dramatic transformation images or precise improvement percentages without adequate supporting evidence.
4. Skincare, Skin Protection and Dermatological Benefits
Another area of concern involved claims related to skin enhancement, skin lightening and protection against ultraviolet (UV) damage.
The report highlighted claims suggesting exceptionally large improvements in skin defence, including a claim of 300% stronger protection against UV damage.
Such statements raise questions about the underlying research, the method used to measure the improvement and whether the evidence applies to the actual product being advertised.
For consumers, an important distinction is that a supplement should not automatically be considered a substitute for established skincare practices or recommended sun protection.
For advertisers, numerical claims and comparisons require particular care. A percentage improvement should have a clearly defined basis and credible evidence supporting the stated result.
5. Respiratory Health Claims and Serious Medical Conditions
Some of the most concerning examples involved advertisements that appeared to extend beyond general wellness support into claims associated with specific diseases.
The report highlighted concerns relating to respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Other disease-related claims mentioned in coverage of the report included those involving blood pressure, cholesterol and polycystic ovary syndrome (PCOS).
Advertising that implies a supplement can reverse a chronic condition or replace established medical treatment can create serious risks if consumers interpret the claim as a reason to avoid appropriate care.
Nutritional support and medical treatment serve different purposes. The presence of an ingredient associated with a physiological benefit does not establish that a supplement can treat or cure a disease.
Important: People living with asthma, COPD or other chronic conditions should not discontinue prescribed medication or delay medical treatment because of an advertisement for a nutraceutical product.
Why Scientific Evidence Matters in Nutraceutical Advertising
One of the report’s central concerns was the gap between evidence about individual ingredients and evidence supporting the claims made for finished products.
This distinction is important for understanding why an advertisement may be misleading even when it refers to published scientific research.
Ingredient Research Is Not the Same as Product Evidence
Suppose a company sells a supplement containing an ingredient that has been studied for a particular health benefit.
That research alone does not necessarily prove that the company’s finished product will produce the same result.
The outcome may depend on several factors:
- The ingredient’s actual concentration and daily dosage.
- The formulation and combination of ingredients.
- The quality and bioavailability of the ingredients.
- The population studied and its health characteristics.
- The study design, duration and measured outcomes.
- Whether the available evidence supports the exact claim used in the advertisement.
For example, a study investigating one ingredient at a specific dosage cannot automatically substantiate a claim that a different formulation produces rapid weight loss or reverses a medical condition.
ASCI’s report highlighted the need for evidence that supports the actual product and the specific benefits being advertised, rather than relying solely on ingredient-level research.
Why Before-and-After Images Can Be Misleading
Visuals play a powerful role in health and wellness marketing.
A photograph showing dramatic weight loss, younger-looking skin or a transformation in lung appearance may lead consumers to believe that the advertised product directly caused the improvement.
However, an image alone cannot establish causation.
Before-and-after comparisons may fail to communicate important information, including the individual’s starting condition, other lifestyle changes, the time involved and the reliability of the measurement.
Advertisers should ensure that images, testimonials, demonstrations and supporting text do not collectively create an impression that exceeds what the scientific evidence can justify.
Comparative Claims Need a Clear Basis
Words such as faster, stronger, better and more effective can imply that a product outperforms an alternative.
Such comparisons should have a clear reference point and reliable evidence supporting the claimed advantage.
Without a meaningful benchmark, consumers may struggle to understand what the comparison actually measures.
For responsible health marketing, every significant claim should be clear, relevant and supported by appropriate evidence.
ASCI and FSSAI: Understanding the Regulatory Framework
The report has renewed attention on the responsibilities of businesses that manufacture, market and advertise nutraceutical products in India.
Two important bodies in this area are ASCI and the Food Safety and Standards Authority of India (FSSAI). Their roles are related to consumer protection but are not identical.
What Does ASCI Do?
ASCI focuses on advertising self-regulation and the responsible presentation of advertising claims.
Its review highlights whether advertisements comply with the ASCI Code, including expectations around truthfulness and substantiation.
The latest report demonstrates that advertisers may face challenges when they cannot provide adequate evidence for the benefits promised in their campaigns.
What Does FSSAI Do?
FSSAI is India’s statutory food safety regulator. Its regulatory framework covers health supplements, nutraceuticals and other specialised food categories.
The Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016, establish requirements applicable to these product categories. Advertising and claims are also addressed through the relevant food safety regulations.
The framework is important because nutraceuticals are not simply interchangeable with medicines.
In particular, the applicable rules restrict disease-treatment claims for nutraceuticals. General wellness or structure-and-function statements must also satisfy the relevant requirements.
Businesses should therefore review their product formulations, labelling, supporting evidence and promotional materials against the applicable regulations.
Key takeaway: Compliance with advertising standards and food regulations should be considered together. Businesses should not assume that a product’s availability in the market automatically validates every health claim made about it.
How Can Consumers Identify Potentially Misleading Supplement Advertisements?
The ASCI findings provide a useful opportunity for consumers to become more informed when evaluating health and wellness products.
Before purchasing a supplement, consider the following checks.
1. Be Sceptical of Guaranteed Results
Claims such as guaranteed weight loss, instant improvement or complete reversal of ageing deserve careful scrutiny.
Health outcomes can vary considerably between individuals. A specific outcome should not be assumed to be achievable merely because an advertisement promises it.
2. Look Beyond Influencer Recommendations
A celebrity endorsement, influencer testimonial or positive customer review is not a substitute for scientific evidence.
Personal experiences may be genuine, but they cannot independently establish that a product produces the same results for other consumers.
3. Check the Product Label
Review the ingredients, serving instructions, warnings, manufacturer details and applicable regulatory information.
In India, consumers can also consult official FSSAI resources to understand the regulatory framework for health supplements and nutraceuticals.
A label or registration detail, however, should not be interpreted as independent proof of every advertised benefit.
4. Question Claims About Treating Diseases
Be especially cautious when an advertisement suggests that a supplement can cure, reverse or replace treatment for a diagnosed medical condition.
Consult a qualified healthcare professional before using supplements to address a medical concern.
5. Ask What Evidence Supports the Claim
Look for reliable research that relates to the finished product, its dosage and the specific advertised benefit.
If a company refers to a scientific study, consider whether the research actually examined the product being sold or merely an ingredient that it contains.
6. Avoid Replacing Medical Advice With Marketing Promises
Supplements may have a role in addressing certain nutritional needs, but their suitability depends on the individual and the circumstances.
People taking medication or managing chronic health conditions should seek appropriate professional advice before introducing supplements into their routine.
What the ASCI Report Means for Nutraceutical Brands and Digital Marketers
The report has implications beyond product manufacturers. It also offers important lessons for advertising agencies, digital marketing teams, influencers, e-commerce businesses and publishers involved in promoting health-related products.
As consumers increasingly discover supplements through search engines, social media, influencer content and online marketplaces, promotional claims can influence purchasing decisions across multiple channels.
Brands should therefore consider the following practices.
Evidence-first marketing: Establish the supporting evidence before developing a headline, campaign or product promise.
Product-specific substantiation: Verify that the available research supports the finished formulation and the exact claim being communicated.
Responsible use of numbers: Ensure that percentages, timelines and comparative claims have a clear, defensible basis.
Careful visual communication: Review before-and-after images, demonstrations and testimonials for misleading implications.
Clear distinction between wellness and treatment: Avoid presenting a dietary supplement as a replacement for medical diagnosis, prescribed treatment or established clinical care.
Consistent compliance reviews: Assess claims across websites, paid advertisements, social media posts, influencer collaborations, product pages and packaging.
These steps can help businesses reduce the risk of misleading communication while building stronger, longer-term consumer trust.
Responsible advertising is not simply a matter of avoiding regulatory problems. It is also an important part of protecting a brand’s credibility in a competitive market.
Frequently Asked Questions (FAQs)
1. What did ASCI’s 2026 nutraceutical advertising report find?
ASCI’s report, A Pill for Thought: Review of Health and Wellness Claims in Nutraceutical Advertising, examined 61 advertisements published between July and September 2026. All 60 completed reviews found violations of the ASCI Code, while one case remained under process.
2. Why were the nutraceutical advertisements flagged by ASCI?
The advertisements were flagged because advertisers did not provide adequate substantiation for their health and wellness claims. The concerns included exaggerated weight-loss promises, anti-ageing claims, skincare benefits, UV protection and representations relating to respiratory health and medical conditions.
3. Does the report mean that all nutraceutical products are ineffective?
No. The report assessed advertising claims and their supporting evidence, not the effectiveness or safety of every nutraceutical product available in India. Its findings indicate that the advertisements reviewed did not adequately substantiate their claims.
4. What is the difference between a nutraceutical and a medicine?
Nutraceuticals and health supplements are regulated food categories intended for permitted nutritional or other relevant benefits under the applicable framework. Medicines are subject to a separate regulatory framework. A nutraceutical should not be assumed to treat or cure a disease simply because it contains an ingredient studied for a health-related effect.
5. What role does FSSAI play in nutraceutical regulation?
FSSAI establishes and administers India’s food safety framework, including regulations covering health supplements and nutraceuticals. Relevant requirements address product categories, labelling, safety and permitted claims. Businesses must follow the applicable regulations when marketing these products.
6. How can consumers verify health claims made by supplement brands?
Consumers can review product labels, examine the quality of supporting scientific evidence, check relevant regulatory information and consult qualified healthcare professionals. They should be cautious of guaranteed results, unsupported comparisons and advertisements suggesting that supplements can replace medical treatment.
7. Can a nutraceutical advertisement use scientific research to support its claims?
Scientific research can support appropriate claims when the evidence is relevant and sufficiently robust. However, research on an individual ingredient does not automatically prove that a finished product will deliver a specific benefit. The evidence must be appropriate to the formulation, dosage and claim being made.
Conclusion: Scientific Evidence Must Come Before Health Promises
ASCI’s A Pill for Thought report sends an important message to India’s nutraceutical industry: health and wellness advertising should be based on evidence, not simply persuasive promises.
The finding that all 60 completed advertisement reviews violated the ASCI Code highlights the need for stronger claim substantiation and more responsible communication.
For consumers, the report reinforces the importance of looking beyond marketing language and evaluating health-related claims carefully.
For brands, manufacturers and digital marketers, it underlines the importance of building campaigns around credible evidence, transparent communication and applicable regulatory requirements.
As the nutraceutical market evolves, sustainable growth will depend not only on product innovation but also on consumer confidence.
Ultimately, a health claim should be only as strong as the evidence supporting it.